Pfizer signs deal to produce and flexibly Gilead’s remdesivir for COVID-19 treatment

Overview

• Post By : Kumar Jeetendra


• Source: Reuters


• Date: 07 Aug,2020

The US drugmaker would provide contract manufacturing services in its facility in Kansas to create the medication.
Pfizer Inc said on Friday it signed up a multi-year agreement with Gilead Sciences Inc to manufacture and provide the organization’s antiviral drug remdesivir for COVID-19 patients.

The US drugmaker would provide contract manufacturing services at its center in Kansas to produce the drug.